Fine-tuning on the 3rd of Chinese medicine combined with chemotherapy in treatment of advanced non-small cell lung cancer 120 cases of.docVIP

 PAGE \* MERGEFORMAT 8 Fine-tuning on the 3rd of Chinese medicine combined with chemotherapy in treatment of advanced non-small cell lung cancer 120 cases of [Keywords:] non-small cell lung cancer;,, fine-tuning on the 3rd Chinese medicine;,, Chinese medicine;, and chemotherapy Abstract: Objective To observe the effects of fine-tuning on the 3rd combination chemotherapy in advanced non-small cell lung cancer. Methods the control group NP chemotherapy, the treatment group with oral administration of traditional Chinese medicine decoction fine-tuning on the 3rd. Observation of clinical symptoms, tumor, quality of life, weight, tumor radioimmunoassay, chemotherapy side effects, long-term efficacy and other indicators. Results The main clinical symptoms in the treatment group improved (total effective rate was 81.67%), stable tumor 〔 PR duration (12.0 ± 2.5) months〕 improve the quality of life (overall response rate 85.00%), increased body weight (total effective rate was 83.33%) reduce the tumor RIA (total effective rate 80.00%), reducing the incidence of chemotherapy toxicity, such as 3-year survival rate compared with the control group, there are significant differences. Conclusion fine-tuning on the 3rd of Chinese medicine can enhance effect of chemotherapy, significantly reduce the toxicity of chemotherapy, the overall effect of the total yield of 78.33%, 3-year survival rate was 30.00%. Keywords:: non-small cell lung cancer; medicine fine-tuning on the 3rd; Chinese medicine; chemotherapy Lung, one of the most common malignant tumor, the treatment of advanced non-small cell lung cancer difficult to poorer treatment outcomes. I Division of the 1998-07 ~ 2004-07 hospitalization of 120 patients with advanced non-small cell lung cancer patients have been fine-tuning on the 3rd of Chinese medicine combined with chemotherapy, and achieved a certain effect. Reports are summarized below. 1 Data and methods 1.1 General information for advanced non-small cell lu